Fig. 6From: Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastasesIntensities from the targeted MS approach for 8 of the 9 proteins from the discriminative signature listed in Table 3. Statistics for this plot were done in MSstats (*p value < 0.05, **p value < 0.01, ***p value < 0.001)Back to article page